Progression anxiety in patients with brain tumors and their caregivers

Progression anxiety in patients with brain tumors and their caregivers - ProAn

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034637

Enrollment

200

Registered

2024-07-10

Start date

2019-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71

Interventions

Group 1: Assessment of psychological questionnaires of patients with an initial diagnosis of a brain tumor or brain metastasis at 3 points in time: T0=3-7 days after diagnosis, T1=3 months after diagn

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: legal capacity, further treatment at the neuro-oncology center of the UK Düsseldorf, C71 diagnosis, sufficient knowledge of German, participation of the patient together with the caregiver

Exclusion criteria

Exclusion criteria: Severe cognitive impairment

Design outcomes

Primary

Measure	Time frame
Fear of cancer progression (PAF-KF/PAF-KF-P)	—

Secondary

Measure	Time frame
Anxiety (HADS-A), depression (HADS-D), distress (NCCN Distress Thermometer), quality of life (EORTC-QLQ-C30), sociodemographic and clinical characteristics	—

Countries

Germany

Contacts

Public ContactAndré Karger

Universitätsklinikum Düsseldorf

Andre.Karger@med.uni-duesseldorf.de+492118116212

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026